Kainos Medicine, Inc. engages in the research and development of pharmaceutical products. It develops degenerative brain disease treatment, anti-viral, and anti-cancer drugs. The company was founded on June 15, 2007 and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company